The role of nucleo-cytoskeletal link proteins in skeletal muscle
核细胞骨架连接蛋白在骨骼肌中的作用
基本信息
- 批准号:8003272
- 负责人:
- 金额:$ 34.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:AblationAddressAdultAge-MonthsAllelesBindingBiochemicalBiological ProcessBiologyBody WeightC-terminalCardiacCell NucleusCellsCongenital Heart DefectsContractureCytoskeletonDataDefectDesminEmery-Dreifuss Muscular DystrophyExerciseExhibitsFamilyGene ExpressionGenesGenetically Engineered MouseGoalsIn VitroIntermediate FilamentsKineticsKnock-outKnockout MiceLamin Type ALightLinkMechanicsMembrane ProteinsMicrofilamentsModelingMolecularMusMuscleMuscle FibersMuscle WeaknessMuscle functionMuscular DystrophiesMutant Strains MiceMutationMyoblastsMyopathyN-terminalNuclearNuclear EnvelopeNuclear Inner MembraneNuclear LaminaNuclear Outer MembraneNull LymphocytesOrganismPathogenesisPatientsPerinatalPhenotypePhysiologicalPositioning AttributeProtaminesProtein FamilyProteinsRespiratory FailureRoleSignal TransductionSkeletal MuscleSkeletal MyoblastsSpectrinStretchingSurvivorsSynapsesTamoxifenTestingcalponinemerinimprovedin vivoinsightlink proteinloss of functionmembermutantpublic health relevanceresearch studyretinal rodssatellite cell
项目摘要
DESCRIPTION (provided by applicant): Recent data suggest that mutations in Nesprin 1 and 2 may be involved in the pathogenesis of Emery-Dreifuss muscular dystrophy (EDMD), which is characterized by progressive skeletal muscle weakness with associated muscle contractures, and variable cardiac defects. 40% of patients with EDMD have been shown to have mutations in Emerin or Lamin A/C, two genes encoding proteins localized to the inner nuclear membrane (INM) and its underlying lamina, respectively. The INM, the outer nuclear membrane (ONM), and the nuclear lamina comprise the nuclear envelope, which is linked to the cytokeleton by members of both the SUN and Nesprin protein families. Approximately 60% of EDMD patients do not have mutations in either Emerin or LMNA. Intriguingly, mutations in Nesprin 1 and 2 have been associated with EDMD. Nesprins belong to a newly discovered family of mammalian spectrin-repeat proteins. Mice lacking Lamin A/C exhibit features of EDMD. Studies on skeletal muscle cultures isolated from these mice have demonstrated a critical role for Lamin A/C in skeletal myoblast differentiation and in mechanical stiffness by maintaining nucleo-cytoskeletal integrity. In contrast, Emerin knockout mice do not exhibit EDMD. However, in skeletal muscle cultures from Emerin null mice, myoblast differentiation is perturbed to the same extent as observed in Lamin A/C null cells. Moreover, although Emerin null cells do not exhibit decreased mechanical stiffness as found in Lamin A/C null cells, perturbations in gene expression associated with mechanotransduction are observed. Both Nesprin 1 and 2 are ubiquitously expressed. To investigate the functional roles of Nesprin 1 and 2, we have generated floxed alleles for Nesprin 1 and 2. By utilizing protamine Cre mice, we have generated global loss of function mutants for Nesprin 1 and 2 (Nesprin 1-/- and Nesprin 2-/-). Our studies reveal that Nesprin 2-/- mice are viable and have no obvious basal phenotype, whereas approximately 60% of Nesprin 1-/- mice die perinatally. Remaining survivors have reduced body weight and compromised exercise capacity. We also found 100% perinatal lethality in Nesprin 1-/-;Nesprin 2-/- double mutant mice. Histological analyses of Nesprin 1-/- mice and Nesprin 1-/-;Nesprin 2-/- mice revealed abnormal positioning of non-synaptic nuclei and disappearance of clusters of synaptic nuclei. The overall goals of this proposal are to test the hypothesis that Nesprin 1 and 2 have distinct and overlapping roles in skeletal muscle nuclear positioning, nuclear membrane integrity, skeletal myoblast differentiation, mechanical stiffness, mechano-transduction, and muscle function. We will achieve these goals by comprehensive molecular, biochemical, histological, and physiological analysis of the skeletal muscle phenotypes in our four existing genetically engineered mouse lines. Results will shed light into mechanisms by which mutations in Nesprin contribute to myopathies.
PUBLIC HEALTH RELEVANCE: Mutations in Nesprin 1 and 2 may be involved in the pathogenesis of Emery-Dreifuss muscular dystrophy (EDMD). The proposed studies will help us to understand the biological function of Nesprin 1 and 2 in skeletal muscle at molecular, cellular, and physiological levels and to gain insight into mechanisms by which mutations in Nesprin 1 and 2 are involved in the pathogenesis of EDMD, thereby improving our general understanding of EDMD and other types of muscular dystrophy. In addition, the mouse lines will be useful as test models for potential therapies.
描述(由申请人提供):最近的数据表明,Nesprin 1 和 2 的突变可能与 Emery-Dreifuss 肌营养不良症 (EDMD) 的发病机制有关,其特征是进行性骨骼肌无力并伴有肌肉挛缩和各种心脏缺陷。 40% 的 EDMD 患者已被证明存在 Emerin 或 Lamin A/C 突变,这两个基因分别编码位于内核膜 (INM) 及其底层的蛋白质。 INM、外核膜 (ONM) 和核纤层构成核膜,核膜通过 SUN 和 Nesprin 蛋白家族的成员与细胞骨架相连。大约 60% 的 EDMD 患者在 Emerin 或 LMNA 中没有突变。有趣的是,Nesprin 1 和 2 的突变与 EDMD 相关。 Nesprin 属于新发现的哺乳动物血影蛋白重复蛋白家族。缺乏核纤层蛋白 A/C 的小鼠表现出 EDMD 的特征。对从这些小鼠中分离出的骨骼肌培养物进行的研究表明,Lamin A/C 在骨骼肌成肌细胞分化和通过维持核细胞骨骼完整性来维持机械刚度方面发挥着关键作用。相比之下,Emerin 基因敲除小鼠不表现出 EDMD。然而,在 Emerin 缺失小鼠的骨骼肌培养物中,成肌细胞分化受到干扰的程度与在 Lamin A/C 缺失细胞中观察到的程度相同。此外,尽管 Emerin 无效细胞没有像 Lamin A/C 无效细胞那样表现出机械刚度降低,但观察到与机械转导相关的基因表达的扰动。 Nesprin 1 和 2 均普遍表达。为了研究 Nesprin 1 和 2 的功能作用,我们生成了 Nesprin 1 和 2 的 floxed 等位基因。通过利用鱼精蛋白 Cre 小鼠,我们生成了 Nesprin 1 和 2 的整体功能丧失突变体(Nesprin 1-/- 和 Nesprin 2) -/-)。我们的研究表明,Nesprin 2-/- 小鼠能够存活,并且没有明显的基础表型,而大约 60% 的 Nesprin 1-/- 小鼠在围产期死亡。剩下的幸存者体重减轻,运动能力下降。我们还发现 Nesprin 1-/-;Nesprin 2-/- 双突变小鼠的围产期死亡率为 100%。 Nesprin 1-/- 小鼠和 Nesprin 1-/-;Nesprin 2-/- 小鼠的组织学分析显示非突触核定位异常和突触核簇消失。该提案的总体目标是检验 Nesprin 1 和 2 在骨骼肌核定位、核膜完整性、骨骼肌成肌细胞分化、机械刚度、机械传导和肌肉功能中具有不同且重叠的作用的假设。我们将通过对我们现有的四个基因工程小鼠品系的骨骼肌表型进行全面的分子、生化、组织学和生理学分析来实现这些目标。结果将揭示 Nesprin 突变导致肌病的机制。
公共卫生相关性:Nesprin 1 和 2 的突变可能与 Emery-Dreifuss 肌营养不良症 (EDMD) 的发病机制有关。拟议的研究将帮助我们在分子、细胞和生理水平上了解 Nesprin 1 和 2 在骨骼肌中的生物学功能,并深入了解 Nesprin 1 和 2 的突变参与 EDMD 发病的机制,从而提高我们对 EDMD 和其他类型肌营养不良症的总体了解。此外,小鼠品系可用作潜在疗法的测试模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ju Chen其他文献
Ju Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ju Chen', 18)}}的其他基金
ATF4 a Novel Regulator of Cardiac Development
ATF4 心脏发育的新型调节剂
- 批准号:
10657081 - 财政年份:2023
- 资助金额:
$ 34.76万 - 项目类别:
Novel function of a mitochondria phosphatase in cardiac development
线粒体磷酸酶在心脏发育中的新功能
- 批准号:
10436945 - 财政年份:2021
- 资助金额:
$ 34.76万 - 项目类别:
Protein Kinase Novel 2 (PKN2) in heart
心脏中的蛋白激酶 Novel 2 (PKN2)
- 批准号:
10322445 - 财政年份:2021
- 资助金额:
$ 34.76万 - 项目类别:
Protein Kinase Novel 2 (PKN2) in heart
心脏中的蛋白激酶 Novel 2 (PKN2)
- 批准号:
10548141 - 财政年份:2021
- 资助金额:
$ 34.76万 - 项目类别:
Novel function of a mitochondria phosphatase in cardiac development
线粒体磷酸酶在心脏发育中的新功能
- 批准号:
10687847 - 财政年份:2021
- 资助金额:
$ 34.76万 - 项目类别:
Novel function of a mitochondria phosphatase in cardiac development
线粒体磷酸酶在心脏发育中的新功能
- 批准号:
10181409 - 财政年份:2021
- 资助金额:
$ 34.76万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Investigating the coordinated endothelial-epithelial interactions in adult hair cycle of mouse skin
研究小鼠皮肤成年毛发周期中协调的内皮-上皮相互作用
- 批准号:
10674132 - 财政年份:2023
- 资助金额:
$ 34.76万 - 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 34.76万 - 项目类别:
The Role of Bone Sialoprotein in Modulating Periodontal Development and Repair
骨唾液酸蛋白在调节牙周发育和修复中的作用
- 批准号:
10752141 - 财政年份:2023
- 资助金额:
$ 34.76万 - 项目类别:
In vivo feasibility of a smart needle ablation treatment for liver cancer
智能针消融治疗肝癌的体内可行性
- 批准号:
10699190 - 财政年份:2023
- 资助金额:
$ 34.76万 - 项目类别:
LRP1 as a novel regulator of CXCR4 in adult neural stem cells and post-stroke response
LRP1 作为成体神经干细胞和中风后反应中 CXCR4 的新型调节剂
- 批准号:
10701231 - 财政年份:2023
- 资助金额:
$ 34.76万 - 项目类别: